文献速递生殖医学产科

植入前遗传学检测与儿童健康:一项基于全国登记的研究

Preimplantation genetic testing and child health: a national register-based study.
PubMed 文献 · Hum Reprod · 2023-01-01

瑞典基于登记的研究比较了1996年1月1日至2019年9月30日间出生的390例PGT单胎与61060例IVF/ICSI单胎及42034例自然受孕匹配单胎,发现PGT与IVF/ICSI的围产期结局和早期儿童健康相当,但PGT较自然受孕早产风险更高,母体前置胎盘和剖宫产率也更高。

要点

  • PGT与IVF/ICSI相比,早产和低出生体重的调整比值比无显著差异。
  • PGT较自然受孕早产风险升高(AOR 1.73,95%CI 1.17-2.58)。
  • PGT较自然受孕前置胎盘和剖宫产率显著更高,但与IVF/ICSI无差异。

核心结论

  • PGT儿童的围产期结局与IVF/ICSI儿童相当,早期儿童健康结果也相当。
  • PGT儿童较自然受孕儿童早产风险更高,母体前置胎盘和剖宫产率也更高。
  • 作者认为结果令人安心,提示胚胎活检本身对围产期、早期儿童或母体结局无不良影响。
  • 作者指出由于诊断儿童数量少且随访时间短,应谨慎看待早期儿童结局的相当性。
  • 作者建议鉴于该技术的侵入性,应开展PGT儿童的长期随访研究。

研究设计与样本

  • 基于登记的全国性研究,纳入瑞典1996年1月1日至2019年9月30日间出生的所有PGT单胎(n=390)。
  • PGT单胎与同期所有IVF/ICSI单胎(n=61060)及从医学出生登记中选取的匹配自然受孕单胎(n=42034)进行比较。
  • 数据来自瑞典两个PGT中心的本地数据库、全国IVF登记以及医学出生登记、患者登记和死因登记。
  • 采用逻辑多变量回归分析和Cox比例风险模型,并调整相关混杂因素。
  • 主要结局为早产和低出生体重,次要结局为儿童期疾病。

主要发现

  • PGT儿童平均随访4.6年,自然受孕儿童平均随访5.1年,IVF/ICSI儿童平均随访9.0年。
  • 早产发生率PGT为7.7%,IVF/ICSI为7.3%;低出生体重发生率PGT为4.9%,IVF/ICSI为5.2%(AOR 1.22,95%CI 0.82-1.81和AOR 1.17,95%CI 0.71-1.91)。
  • 与自然受孕相比,PGT儿童早产风险更高(AOR 1.73,95%CI 1.17-2.58)。
  • 哮喘绝对风险PGT为38/390(9.7%),IVF/ICSI为6980/61060(11.4%);过敏性疾病分别为34/390(8.7%)和7505/61060(12.3%),Cox模型显示无显著差异。
  • 脓毒症、甲状腺功能减退、注意缺陷多动障碍、孤独症谱系障碍、智力低下、脑瘫和癫痫在PGT儿童中诊断数最多为3例,随访期间无PGT儿童死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • PGT儿童样本量较小,无法调整所有相关混杂因素,包括受精方式和培养时间。
  • 大多数儿童随访时间短,尤其是PGT组,可能降低了早期儿童诊断的绝对数量。
  • PGT儿童诊断数量少且随访时间短,应谨慎看待早期儿童结局与IVF/ICSI相当的结果。
  • PGT儿童长期随访研究 scarce,应开展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is preimplantation genetic testing (PGT) associated with adverse perinatal outcome and early childhood health? SUMMARY ANSWER: Children born after PGT had comparable perinatal outcomes to children born after IVF/ICSI and comparable findings regarding early childhood health. WHAT IS KNOWN ALREADY: PGT is offered to couples affected by monogenic disorders (PGT-M) or inherited chromosomal aberrations (PGT-SR), limiting the risk of transferring the disorder to the offspring. PGT, an invasive technique, requires genetic analysis of one or up to ten cells from the embryo and is combined with IVF or ICSI. Several studies, most of them small, have shown comparable results after PGT and IVF/ICSI concerning perinatal outcome. Only a few studies with limited samples have been published on PGT and childhood health. STUDY DESIGN, SIZE, DURATION: We performed a register-based study including all singletons born after PGT (n = 390) in Sweden during 1 January 1996-30 September 2019. Singletons born after PGT were compared with all singletons born after IVF/ICSI (n = 61 060) born during the same period of time and with a matched sample of singletons (n = 42 034) born after spontaneous conception selected from the Medical Birth Register. Perinatal outcomes, early childhood health, and maternal outcomes were compared between pregnancies after PGT and IVF/ICSI as well as between pregnancies after PGT and spontaneous conception. Primary outcomes were preterm birth (PTB) and low birthweight (LBW) whereas childhood morbidity was the secondary outcome. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data on women who went through PGT and gave birth were obtained from the local databases at the two PGT centres in Sweden, whereas data on IVF treatment for the IVF/ICSI group were obtained from the national IVF registers. These data were then cross-linked to national health registers; the Medical Birth Register, the Patient Register, and the Cause of Death Register. Logistic multivariable regression analysis and Cox proportional hazards models were performed with adjustment for relevant confounders. MAIN RESULTS AND THE ROLE OF CHANCE: The mean follow-up time was 4.6 years for children born after PGT and 5.1 years for children born after spontaneous conception, whereas the mean follow-up time was 9.0 years for children born after IVF/ICSI. For perinatal outcomes, PTB occurred in 7.7% of children after PGT and in 7.3% of children after IVF/ICSI, whereas the rates were 4.9% and 5.2% for LBW (adjusted odds ratio (AOR) 1.22, 95% CI 0.82-1.81 and AOR 1.17, 95% CI 0.71-1.91, respectively). No differences were observed for birth defects. In comparison to spontaneous conception, children born after PGT had a higher risk for PTB (AOR 1.73, 95% CI 1.17-2.58). Regarding early childhood health, the absolute risk of asthma was 38/390 (9.7%) in children born after PGT and 6980/61 060 (11.4%) in children born after in IVF/ICSI, whereas the corresponding numbers were 34/390 (8.7%) and 7505/61 060 (12.3%) for allergic disorders. Following Cox proportional hazards models, no significant differences were found for these outcomes. Sepsis, hypothyroidism, attention deficit hyperactivity disorder, autism spectrum disorders, mental retardation, cerebral palsy, and epilepsy were diagnosed in a maximum of three PGT children. No PGT children died during the follow-up period. Regarding maternal outcomes, the rates of placenta praevia and caesarean delivery were significantly higher after PGT in comparison to spontaneous conception (AOR 6.46, 95% CI 3.38-12.37 and AOR 1.52, 95% CI 1.20-1.92, respectively), whereas no differences were seen comparing pregnancies after PGT and IVF/ICSI. LIMITATIONS, REASONS FOR CAUTION: The rather small sample size of children born after PGT made it impossible to adjust for all relevant confounders including fertilization method and culture duration. Moreover, the follow-up time was short for most of the children especially in the PGT group, probably lowering the absolute number of diagnoses in early childhood. WIDER IMPLICATIONS OF THE FINDINGS: The results are reassuring and indicate that the embryo biopsy itself has no adverse effect on the perinatal, early childhood, or maternal outcomes. Although the results are comparable to IVF/ICSI also regarding early childhood outcome, they should be taken with caution due to the low number of children with diagnoses and short follow-up time. Long-term follow-up studies on children born after PGT are scarce and should be conducted considering the invasiveness of the technique. STUDY FUNDING/COMPETING INTEREST(S): The study was financed by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (LUA/ALF 70940), the Board of National Specialised Medical Care at Sahlgrenska University Hospital and Hjalmar Svensson Research Foundation. There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ginström Ernstad E, Hanson C, Wånggren K, et al. Preimplantation genetic testing and child health: a national register-based study. Hum Reprod. 2023. PMID: 36749096. doi:10.1093/humrep/dead021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。